Merck (MRK) Intangibles (2009 - 2026)

Merck (MRK) reported Intangibles of $25.7 billion for Q1 2026, up 63.38% year-over-year from $15.8 billion in Q1 2025, and down 3.51% quarter-over-quarter from $26.7 billion in Q4 2025.

Merck (MRK) Intangibles (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Intangibles data on file, last reported at $25.7 billion in Q1 2026.

  • Intangibles for Q1 2026 came in at $25.7 billion, up 63.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.7 billion (up 63.38% YoY), and the FY2025 annual result was $26.7 billion, up 62.99% from the prior year.
  • Intangibles eased to $25.7 billion in Q1 2026 per MRK's latest filing, from $26.7 billion in the prior quarter.
  • Over five years, Intangibles peaked at $26.7 billion in Q4 2025 and troughed at $15.2 billion in Q2 2025.
  • A 5-year average of $19.4 billion and a median of $19.2 billion in 2023 frame the typical range for Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Intangibles soared 65.15% in 2022, then retreated 13.75% in 2023.
  • A 5-year view of Intangibles shows it stood at $20.3 billion in 2022, then decreased by 11.14% to $18.0 billion in 2023, then fell by 9.11% to $16.4 billion in 2024, then jumped by 62.99% to $26.7 billion in 2025, then dropped by 3.51% to $25.7 billion in 2026.
  • Business Quant data shows MRK's Intangibles at $25.7 billion in Q1 2026, $26.7 billion in Q4 2025, and $15.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 24.45 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 49.06 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 50.87 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 25.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 16.38 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 52.56 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 18.24 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn - 10.60 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.75 Bn
Dec 31, 2025 26.68 Bn
Sep 30, 2025 15.31 Bn
Jun 30, 2025 15.19 Bn
Mar 31, 2025 15.76 Bn
Dec 31, 2024 16.37 Bn
Sep 30, 2024 17.01 Bn
Jun 30, 2024 16.98 Bn
Mar 31, 2024 17.57 Bn
Dec 31, 2023 18.01 Bn
Sep 30, 2023 19.20 Bn
Jun 30, 2023 19.67 Bn
Mar 31, 2023 19.86 Bn
Dec 31, 2022 20.27 Bn
Sep 30, 2022 21.37 Bn
Jun 30, 2022 22.50 Bn
Mar 31, 2022 23.02 Bn
Dec 31, 2021 22.93 Bn
Sep 30, 2021 13.38 Bn
Jun 30, 2021 13.62 Bn